EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Esculentin-1a Derived Peptides Potentiate Ceftazidime Activity against Multidrug-Resistant KPC-Producing Klebsiella pneumoniae

Dania Al Ismail, Carlo Vetrano, Luisa Torrini iD, Maria Rosa Loffredo, Eeva Tortellini, Alessandra Oliva iD, Bruno Casciaro iD, Matteo Rossi, Alessandra Carattoli, Maria Luisa Mangoni iD

ACS Infectious Diseases · 11.09.2026 · 12 (9) · 3169-3178

DOI: 10.1021/acsinfecdis.6c00366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 06.08.2026. Verfasst von Dania Al Ismail und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemical Sciences ″A. Rossi Fanelli″, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza Univers…. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Ceftazidime, Anti-Bacterial Agents, Amphibian Proteins. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NextGenerationEU, Sapienza Universit? di Roma, Istituto Pasteur-Fondazione Cenci Bolognetti.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbapenemase-producing Klebsiella pneumoniae represents a major clinical threat due to the multidrug-resistant phenotype of this Gram-negative bacterium and to the limited available therapeutic options. Currently, antimicrobial peptides are regarded as promising candidates for the development of novel anti-infective strategies. In this study, the antimicrobial activity of the frog skin-derived antimicrobial peptide Esc(1-21) and its three analogs, an Aib-containing peptide and two variants bearing d-amino acids (i.e., the diastereomer Esc(1-21)-1c and [Aib8]-Esc(1-21)-1c isoform), was evaluated against a panel of clinical carbapenemase-producing Klebsiella pneumoniae isolates. In addition, the ability of these d-amino acid-containing peptides to potentiate the effectiveness of ceftazidime, a widely used third-generation cephalosporin for treatment of severe Gram-negative bacterial infections, was investigated. Mechanistic analyses revealed that Esc(1-21)-1c promotes outer membrane permeabilization, thereby facilitating ceftazidime entry into the periplasmic space. Notably, the peptide/ceftazidime combination treatment resulted in enhanced outer membrane destabilization and increased cytoplasmic membrane perturbation compared to the peptide alone. These findings support a self-reinforcing mechanism in which ceftazidime-mediated cell wall damage further destabilizes the bacterial envelope, promoting additional peptide uptake and amplifying cytoplasmic membrane disruption. Time–kill assays confirmed the superior bactericidal activity of the peptide/ceftazidime combination compared to either agent used alone. Importantly, no outer membrane perturbation was observed in a strain lacking a synergistic response, suggesting that membrane susceptibility is a key determinant of this cooperative interaction. Overall, these results highlight the potential of Esc-derived peptides as adjuvants capable of restoring β-lactam efficacy against multidrug-resistant carbapenemase-producing Klebsiella pneumoniae, offering a promising strategy to combat antimicrobial resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeCeftazidimeAnti-Bacterial AgentsAmphibian ProteinsAntimicrobial Cationic PeptidesDrug SynergismDrug Resistance, Multiple, BacterialMicrobial Sensitivity Testsbeta-LactamasesKlebsiella InfectionsAnimalsThird Generation CephalosporinsBacterial ProteinsHumans

Stichwörter der Autor:innen

Klebsiella pneumoniaeantimicrobial resistancefrog-skin peptidesmembrane perturbationsynergism

Substanzen

CeftazidimeAnti-Bacterial Agentsbeta-Lactamasesesculentin protein, Rana esculentaAmphibian ProteinsThird Generation CephalosporinsBacterial ProteinsAntimicrobial Cationic Peptides

Autor:innen und Institutionen

  • Department of Biochemical Sciences ″A. Rossi Fanelli″, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza University of Rome, 00161Rome, Italy.
  • Department of Molecular Medicine, Sapienza University of Rome, 00185Rome, Italy.
  • Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185Rome, Italy.

ORCID-Profile: Luisa Torrini, Alessandra Oliva, Bruno Casciaro, Maria Luisa Mangoni

Förderung

  • NextGenerationEU
  • Sapienza Universit? di Roma
  • Istituto Pasteur-Fondazione Cenci Bolognetti
  • Fondazione per la Ricerca sulla Fibrosi Cistica

Zitieren

APA

Al Ismail, D., Vetrano, C., Torrini, L., Loffredo, M. R., Tortellini, E., Oliva, A., Casciaro, B., Rossi, M., Carattoli, A., & Mangoni, M. L. (2026). Esculentin-1a Derived Peptides Potentiate Ceftazidime Activity against Multidrug-Resistant KPC-Producing Klebsiella pneumoniae. ACS Infectious Diseases, 12(9), 3169-3178. https://doi.org/10.1021/acsinfecdis.6c00366

Vancouver

Al Ismail D, Vetrano C, Torrini L, Loffredo MR, Tortellini E, Oliva A, et al. Esculentin-1a Derived Peptides Potentiate Ceftazidime Activity against Multidrug-Resistant KPC-Producing Klebsiella pneumoniae. ACS Infectious Diseases. 2026;12(9):3169-3178. doi:10.1021/acsinfecdis.6c00366

BibTeX
@article{AlIsmail2026,
  author = {Al Ismail, Dania and Vetrano, Carlo and Torrini, Luisa and Loffredo, Maria Rosa and Tortellini, Eeva and Oliva, Alessandra and Casciaro, Bruno and Rossi, Matteo and Carattoli, Alessandra and Mangoni, Maria Luisa},
  title = {Esculentin-1a Derived Peptides Potentiate Ceftazidime Activity against Multidrug-Resistant KPC-Producing Klebsiella pneumoniae},
  journal = {ACS Infectious Diseases},
  year = {2026},
  volume = {12},
  number = {9},
  pages = {3169--3178},
  doi = {10.1021/acsinfecdis.6c00366}
}
Kostenlos starten →